Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
strategic review
Biotech
LianBio lays off half of workforce as biotech winds down
LianBio has become the latest biotech to throw in the towel after conducting a four-month strategic review of the business.
James Waldron
Feb 13, 2024 9:10am
Windtree's search for help shifts to full company sale
Jan 31, 2024 10:35am
2seventy splits again, sending cell therapy R&D to Regeneron
Jan 30, 2024 1:30pm
Gene editing biotech Graphite merges into vision loss biotech
Nov 15, 2023 9:57am
Atreca cuts head count by 40% for 2nd time in 3 months
Nov 15, 2023 7:50am
Kezar offloads 41% of staff, CEO to keep lupus candidate affloat
Oct 4, 2023 7:40am